STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13D/A] Galapagos NV SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

EcoR1 Capital files Amendment No. 3 to Schedule 13D on Galapagos NV (GLPG). The biotech-focused hedge fund and its founder Oleg Nodelman now report beneficial ownership of 8,714,522 ordinary shares/ADSs, equal to 13.22 % of the 65,897,071 shares outstanding (Form 20-F, 31 Dec 2024). The position is concentrated in EcoR1 Capital Fund Qualified, L.P. (8.19 m shares, 12.43 %) while EcoR1 Capital Fund, L.P. holds 0.52 m shares (0.79 %).
The shares were accumulated for an aggregate US$399.4 million; an additional US$293,693 in fees was paid to Citibank for converting ADSs into ordinary shares. EcoR1 and Mr Nodelman have shared voting and dispositive power over the entire stake.
Apart from updating share totals and cost, the filing makes no changes to the previously stated purpose of the investment or to any contracts, arrangements or relationships with the issuer. Exhibit 99.2 details trades executed in the past 60 days; no other transactions were disclosed.

Positive
  • EcoR1 Capital’s 13.22 % stake demonstrates significant institutional confidence in GLPG.
  • US$399.4 million invested underscores long-term commitment from a biotech-focused fund.
Negative
  • None.

Insights

TL;DR: EcoR1 now controls 13.22 % of GLPG after spending US$399 m; no new activist intentions disclosed.

Impact: The disclosure confirms a sizeable, above-13 % holding by a specialist biotech investor, signalling continued conviction in Galapagos. The amendment mainly reflects share tally updates and ADS conversion fees, with voting power remaining shared among EcoR1 entities and founder Oleg Nodelman. Absence of purpose changes means investors gain transparency on stake size but no fresh strategic clues. Overall, the filing is noteworthy for ownership concentration yet neutral regarding immediate operational or financial effects.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
The amounts reported include (1) ordinary shares, no par value, of Galapagos NV (the "Issuer") and (2) American Depositary Shares, each of which represents one ordinary share, no par value, of the Issuer. Based on 65,897,071 ordinary shares outstanding as of December 31, 2024, as reported in the Issuer's Form 20-F filed with the U.S. Securities and Exchange Commission (the "SEC") on March 27, 2025 (the "Form 20-F").


SCHEDULE 13D




Comment for Type of Reporting Person:
The amounts reported include (1) ordinary shares, no par value, of the Issuer and (2) American Depositary Shares, each of which represents one ordinary share, no par value, of the Issuer. Based on 65,897,071 ordinary shares outstanding as of December 31, 2024, as reported in the Issuer's Form 20-F.


SCHEDULE 13D




Comment for Type of Reporting Person:
The amounts reported include (1) ordinary shares, no par value, of the Issuer and (2) American Depositary Shares, each of which represents one ordinary share, no par value, of the Issuer. Based on 65,897,071 ordinary shares outstanding as of December 31, 2024, as reported in the Issuer's Form 20-F.


SCHEDULE 13D




Comment for Type of Reporting Person:
The amounts reported include (1) ordinary shares, no par value, of the Issuer and (2) American Depositary Shares, each of which represents one ordinary share, no par value, of the Issuer. Based on 65,897,071 ordinary shares outstanding as of December 31, 2024, as reported in the Issuer's Form 20-F.


SCHEDULE 13D


EcoR1 Capital, LLC
Signature:/s/ Oleg Nodelman
Name/Title:Manager
Date:07/28/2025
Oleg Nodelman
Signature:/s/ Oleg Nodelman
Name/Title:Reporting Person
Date:07/28/2025
EcoR1 Capital Fund Qualified, L.P.
Signature:/s/ Oleg Nodelman
Name/Title:Manager of the General Partner, EcoR1 Capital, LLC
Date:07/28/2025
EcoR1 Capital Fund, L.P.
Signature:/s/ Oleg Nodelman
Name/Title:Manager of the General Partner, EcoR1 Capital, LLC
Date:07/28/2025

FAQ

How many Galapagos (GLPG) shares does EcoR1 Capital now own?

EcoR1 and affiliates report 8,714,522 ordinary shares/ADSs.

What percentage of GLPG’s outstanding shares is held by EcoR1?

The holding represents 13.22 % of the 65.9 million shares outstanding.

How much has EcoR1 spent acquiring its GLPG position?

The funds paid an aggregate US$399,380,734.97 for the shares, excluding ADS conversion fees.

Did EcoR1 convert ADSs into ordinary GLPG shares?

Yes, the funds paid US$293,693.40 to Citibank to convert ADSs to ordinary shares.

Does the filing change EcoR1’s stated purpose for investing in Galapagos?

No. The amendment reports ownership updates only; the investment purpose remains unchanged.

What is the CUSIP number for Galapagos ordinary shares?

The CUSIP is 36315X101.
Galapagos Nv

NASDAQ:GLPG

GLPG Rankings

GLPG Latest News

GLPG Latest SEC Filings

GLPG Stock Data

2.01B
49.19M
25.35%
22.9%
2.44%
Biotechnology
Healthcare
Link
Belgium
Mechelen